Focus on Multi-targeted Role of Curcumin: a Boon in Therapeutic Paradigm.
Madhuri GroverTarapati RanaMonika SachdevaSimona BungaoLotfi AleyaDhruv SetiaPublished in: Environmental science and pollution research international (2021)
Curcumin is a polyphenolic compound that exhibited good anticancer potential against different types of cancers through its multi-targeted effect like the termination of cell proliferation, inflammation, angiogenesis, and metastasis, thereby acting as antiproliferative and cytotoxic in nature. The present review surveys the various drug combination tried with curcumin or its synthetic analogues and also the mechanism by which curcumin potentiates the effect of almost every drug. In addition, this article also focuses on aromatherapy which is gaining much popularity in cancer patients. After thoroughly studying several articles on combination therapy of curcumin through authenticated book chapters, websites, research, and review articles available at PubMed, ScienceDirect, etc., it has been observed that multi-targeted curcumin possess enormous anticancer potential and, with whatever drug it is given in combination, has always resulted in enhanced effect with reduced dose as well as side effects. It is also capable enough in overcoming the problem of chemoresistance. Besides this, aromatherapy also proved its potency in reducing cancer-related side effects. Combining all the factors together, we can conclude that combination therapy of drugs with curcumin should be explored extensively. In addition, aromatherapy can be used as an adjuvant or supplementary therapy to reduce the cancer complications in patients.
Keyphrases
- combination therapy
- cell proliferation
- cancer therapy
- end stage renal disease
- newly diagnosed
- emergency department
- chronic kidney disease
- risk factors
- ejection fraction
- squamous cell carcinoma
- cross sectional
- young adults
- stem cells
- prognostic factors
- cell cycle
- climate change
- cell therapy
- mesenchymal stem cells
- vascular endothelial growth factor
- risk assessment
- squamous cell
- childhood cancer
- molecular dynamics simulations